Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/25/23 → 05/28/26 |
Funding
- PPD Investigator Services LLC: $43,045.60
Karuna Therapeutics: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety adn Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer's Disease
- Palekar, Nikhil (PI)
- Christodoulou, Christopher (CoPI)
Project: Research